← All companies
Arcus Biosciences, Inc.
RCUS - CIK 0001724521
Market cap$2.78 B
Rank#1869
SEC filings567
The table below shows Arcus Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $201.00M | $238.00M | $248.00M | $192.00M | $201.00M | $156.00M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.